SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (318)2/26/2003 11:21:37 AM
From: Jibacoa  Respond to of 3722
 
NERX Is up 17.8% on volume of 95.K (Ahead of its daily average.)

It announced yesterday, after the market closed, that it has submitted to the FDA data from its phase II STR in patients with multiple myeloma.(It also has submitted to the FDA a revised proposal for further clinical development of STR that it plans to use with high-dose chemotherapy and stem cell transplantation to treat MM.)

siliconinvestor.com

Bernard



To: Jibacoa who wrote (318)2/26/2003 2:05:46 PM
From: Mike  Read Replies (1) | Respond to of 3722
 
Thanks for the message. I love this stock and the "story" behind it. Lets hope we have a bullish close at the days high. Even if we dont get the close at the high we have a bullish chart pattern.

This one will without question have legs going forward.

Mike


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News